Swab and Swabstick Drug Products Recalled for Inadequate Manufacturing Validation
Busse Convenience kits containing swab/swabstick drug products manufactured by Professional Disposables International (PDI) have been recalled due to uncertainty regarding the adequacy of manufacturing test method validation.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of medical swab drug products with a manufacturing validation issue. No illnesses or injuries have been reported. The hazard is characterized by uncertainty in manufacturing test method validation, which represents a theoretical risk-of-harm in products used in healthcare settings, fitting the criteria for High severity.
Plain-English summary
Busse Convenience kits containing swab/swabstick drug products manufactured by Professional Disposables International (PDI) have been recalled. The recalled products bear Lot Numbers 2130419, 2130880, and 2131187, with UDI 00849233005655. Distribution is nationwide.
The recall is due to uncertainty regarding the adequacy of the validation of the test methods used to manufacture the drug products. This means the manufacturing processes may not have been validated sufficiently to ensure the reliability and quality of the products.
The recalling firm is Busse Hospital Disposables, Inc. A total of 96 units are affected by this recall.
The recalled product
- Product
- Universal Tray Catalog 1567
- Manufacturer
- Busse Hospital Disposables, Inc.
- Category
- Drug — Swabs/Swabsticks
- Hazard
- manufacturing-validation-issue
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot Numbers: 2130419 2130880 2131187 UDI: 00849233005655
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAccucaine Lidocaine Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-08
- SevereChloraPrep One-Step Sterile Solution Lacks Assurance of Sterility
FDA (Drugs) · 2026-07-08
- SevereChloraPrep One-Step Applicators Recalled for Lack of Sterile Assurance
FDA (Drugs) · 2026-07-08
- SevereChloraPrep One-Step Antiseptic Applicators recalled for lack of sterility assurance
FDA (Drugs) · 2026-07-08